Biotech Exec Admits Insider Trading On Dimension Deal Talks
A longtime biotech executive pled guilty Tuesday to trading on confidential information to get out ahead of the market and reel in profits when he learned of a planned 2017 acquisition...To view the full article, register now.
Already a subscriber? Click here to view full article